Evidence map›Paper›PMID 42286176›Full record

ReviewNature reviews. Neuroscience2026

The AMPA receptor life cycle: assembly, regulation and synaptic diversity.

Derek Bowie, Xin-Tong Wang, Federico Miguez-Cabello, Amanda M Perozzo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Derek BowieDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada. derek.bowie@mcgill.ca.ORCID http://orcid.org/0000-0001-9491-8768
Xin-Tong WangDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Federico Miguez-CabelloDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Amanda M PerozzoDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0001-9681-3548

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AMPA receptors (AMPARs) mediate the majority of fast excitatory neurotransmission in the mammalian brain. Recent structural, functional and proteomic advances have reshaped our understanding of how these receptors assemble, gate and diversify within distinct synaptic environments. Notably, AMPAR function is governed by an interlocking set of regulatory layers that include alternative splicing and RNA editing within regions of the receptor subunits responsible for gating and permeation, and direct allosteric coupling with different families of auxiliary proteins. The assembly of AMPARs through a dedicated endoplasmic reticulum biogenesis pathway ensures accurate tetramer formation and provides a regulatory checkpoint for synaptic receptor abundance. Brain development introduces additional layers of control as editing, splicing and auxiliary-subunit expression shift from embryonic to adult states, whereas interactions with extracellular proteins contribute to the organization and diversification of synaptic architecture across circuits. Thus, AMPARs are dynamic macromolecular assemblies whose diversity underlies the breadth of glutamatergic signalling in health and disease. This Review synthesizes these emerging principles, highlighting how AMPARs transition from their molecular 'birth' to their deployment at functionally specialized synapses.

Indexed as

BrainReceptors, AMPASynapsesSynaptic TransmissionAnimalsHumansNeurodevelopmentReceptors, AMPA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.